Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study
MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of ...







